Windtree Therapeutics Inc’s recent filing unveils that its President and CEO Fraser Craig acquired Company’s shares for reported $4942.0 on Oct 08 ’24. In the deal valued at $0.91 per share,5,431 shares were bought. As a result of this transaction, Fraser Craig now holds 8,638 shares worth roughly $1382.08.
Ladenburg Thalmann initiated its Windtree Therapeutics Inc [WINT] rating to a Buy in a research note published on June 26, 2020; the price target was $12.25.
Price Performance Review of WINT
On Monday, Windtree Therapeutics Inc [NASDAQ:WINT] saw its stock fall -11.66% to $0.16. Over the last five days, the stock has lost -27.75%. Windtree Therapeutics Inc shares have fallen nearly -54.68% since the year began. Nevertheless, the stocks have fallen -98.09% over the past one year. While a 52-week high of $14.75 was reached on 01/02/25, a 52-week low of $0.17 was recorded on 01/27/25. SMA at 50 days reached $0.3702, while 200 days put it at $3.3900.
Levels Of Support And Resistance For WINT Stock
The 24-hour chart illustrates a support level at 0.1524, which if violated will result in even more drops to 0.1464. On the upside, there is a resistance level at 0.1669. A further resistance level may holdings at 0.1754. The Relative Strength Index (RSI) on the 14-day chart is 18.17, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0547, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.16%. Stochastics %K at 4.01% indicates the stock is a buying.
How much short interest is there in Windtree Therapeutics Inc?
A steep rise in short interest was recorded in Windtree Therapeutics Inc stocks on 2024-11-15, dropping by 17833.0 shares to a total of 30861.0 shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 48694.0 shares. There was a decline of -57.78%, which implies that there is a negative sentiment for the stock.
